RE: Activ 228 Jun 2021 07:42
This looks interesting.... SpectrumX
“....The above figures represent the “expected near-term sales” of hand sanitizer and do not take into account the significant potential of SPC-069, a respiratory candidate that will soon enter Phase II clinical trials in Austria.
The 240 study participants will undergo a 10-day treatment, which means that the results of the study will be available relatively quickly, perhaps six weeks after the start of the evaluation, says Damien Hancox, CEO of SpectrumX.
“Anecdotally, we saw excellent improvement within 72 hours,” he adds.
With this in mind, Hancox and his team contacted the newly formed British Anti-Viral Task Force to find treatments that could be used at home to combat the more extreme effects of COVID-19.
“They are actively looking; they are currently looking for experimental treatments that are taken orally because our form of therapy is relatively unknown – and the chemistry is brand new – but we are in contact with the right people,” the SpectrumX CEO added.
The product has undergone accreditation testing by HPRA in Europe and has been evaluated as a medical/pharmaceutical product. This was done through Spectrum’s Irish subsidiary.
“Our ultimate goal is for our product to be used as an over-the-counter preventive product in pharmacies. So, if your son or daughter has a cold at school, you go to Boots or Superdrug and buy a nebulizer pre-filled with capsules of our solution,” says Hancox.
As mentioned above, the respiratory drug would be effective for a wide range of infections, from pneumonia to influenza to the common cold, opening up a huge potential market.
“It’s any type of viral or bacterial infection; anywhere in the respiratory tract (upper or lower, respiratory systems), we have the same effective mode of action,” Hancox explains. “Positive nonselectivity makes our treatment for respiratory diseases unique.”
Early milestones have been reached for SpectrumX, including the first data from the Innsbruck team’s Phase II study SPC-069, investigating the drug’s potential for the treatment ..”
https://www.share-talk.com/does-spectrumx-holdings-hold-the-key-to-defeating-antimicrobial-resistance-and-treating-covid-19/?utm_source=mailpoet&utm_medium=email&utm_campaign=the-last-newsletter-total-posts-from-our-blog_2#gs.4z8enw
Trek
Sign In
Follow the stocks
